Compare RITM & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RITM | BIRK |
|---|---|---|
| Founded | 2011 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.5B |
| IPO Year | 2012 | 2023 |
| Metric | RITM | BIRK |
|---|---|---|
| Price | $8.46 | $32.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 23 |
| Target Price | $13.00 | ★ $49.45 |
| AVG Volume (30 Days) | ★ 6.4M | 1.7M |
| Earning Date | 10-23-2026 | 08-13-2026 |
| Dividend Yield | ★ 11.55% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $4,590,228,000.00 | N/A |
| Revenue This Year | $54.48 | $11.96 |
| Revenue Next Year | $7.79 | $13.73 |
| P/E Ratio | $53.97 | ★ $17.48 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.31 | $29.93 |
| 52 Week High | $12.15 | $50.73 |
| Indicator | RITM | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 33.79 | 46.13 |
| Support Level | $8.43 | $31.12 |
| Resistance Level | $9.49 | $33.86 |
| Average True Range (ATR) | 0.22 | 1.10 |
| MACD | 0.01 | 0.18 |
| Stochastic Oscillator | 13.89 | 14.61 |
Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights), loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.